Stocks / Pharmaceuticals
BBIOPharmaceuticals
BridgeBio Pharma, Inc.
$67.321d -1.7%5d -9.0%settled close · 2026-09-17
Mkt cap $13B (3/25)β 1.0752w $49–90Shares 193.9MInd. Pharmaceutical PreparationsNasdaq since 2019Emp. 839HQ Palo Alto, CAbridgebio.com
Who’s talkingIdea Scout · free
Who’s talking about BBIO
No tracked investor commentary on BBIO yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 27 Oct 2026
Confirmed date · consensus EPS -0.65. Reactions below are the next settled session over the prior close.
| Report | When | EPS actual vs est. | Reaction |
|---|---|---|---|
| 10 Aug 2026 | after the close | -0.78 vs -0.60 | -4.5% |
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where BBIO’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 25 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-15 | ||||||
| 2026-09-09 | ||||||
| 2026-09-08 | ||||||
| 2026-08-26 | ||||||
| 2026-08-24 | ||||||
| 2026-08-20 | ||||||
| 2026-08-19 | ||||||
| 2026-07-09 | ||||||
| 2026-06-29 | ||||||
| 2026-06-25 | ||||||
| 2026-06-24 | ||||||
| 2026-06-23 | ||||||
| 2026-06-22 | ||||||
| 2026-06-18 | ||||||
| 2026-04-29 | ||||||
| 2026-04-22 | ||||||
| 2026-04-21 | ||||||
| 2026-04-20 | ||||||
| 2026-04-17 | ||||||
| 2026-04-16 | ||||||
| 2026-04-15 | ||||||
| 2026-04-14 | ||||||
| 2026-04-13 | ||||||
| 2026-04-01 | ||||||
| 2026-03-27 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
BBIO is in this morning’s Brief.
Get The Brief — $20/mo →